US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 26.750
  • +1.030+4.00%
Close Dec 3 16:00 ET
95.98MMarket Cap-3689P/E (TTM)

Aligos Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
-60.82%1.27M
-84.59%1.06M
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
Operating revenue
-60.82%1.27M
-84.59%1.06M
-63.79%986K
11.66%15.53M
-24.20%2.68M
-21.12%3.24M
86.46%6.89M
5.91%2.72M
219.04%13.91M
863.76%3.54M
Cost of revenue
Gross profit
Operating expense
-4.08%21.4M
5.56%27.48M
-13.55%23.03M
-7.02%103.66M
9.38%28.68M
-3.23%22.31M
8.06%26.03M
-30.13%26.64M
-15.97%111.49M
-31.57%26.22M
Selling and administrative expenses
-28.20%4.63M
-31.04%6.38M
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
-General and administrative expense
-28.20%4.63M
-31.04%6.38M
-21.63%6.67M
15.93%30.62M
-9.80%6.42M
22.42%6.44M
22.04%9.25M
31.84%8.51M
-7.42%26.41M
-26.74%7.12M
Research and development costs
5.72%16.77M
25.73%21.1M
-9.75%16.37M
-14.15%73.04M
16.53%22.26M
-10.81%15.87M
1.64%16.78M
-42.75%18.14M
-18.32%85.08M
-33.21%19.1M
Operating profit
-5.56%-20.13M
-38.00%-26.41M
7.83%-22.05M
9.69%-88.13M
-14.62%-26M
-0.65%-19.07M
6.14%-19.14M
32.73%-23.92M
23.96%-97.58M
40.23%-22.68M
Net non-operating interest income expense
-54.53%457K
-66.60%319K
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
Non-operating interest income
-54.53%457K
-66.60%319K
-22.46%580K
-24.21%1.24M
-267.24%-1.47M
115.67%1.01M
350.47%955K
769.77%748K
1,142.42%1.64M
1,447.69%876K
Other net income (expense)
837.04%506K
20,521.71%31.35M
-5,364.96%-13.37M
129.67%54K
-50.00%152K
379.12%254K
Other non- operating income (expenses)
837.04%506K
20,521.71%31.35M
-5,364.96%-13.37M
----
----
129.67%54K
-50.00%152K
379.12%254K
----
----
Income before tax
-6.42%-19.17M
129.11%5.25M
-52.03%-34.84M
9.44%-86.88M
-27.87%-27.92M
3.49%-18.01M
9.27%-18.03M
35.56%-22.92M
25.16%-95.94M
42.19%-21.84M
Income tax
213.79%91K
-75.03%189K
-38.46%24K
650.00%795K
-161.22%-30K
167.44%29K
1,510.64%757K
-26.42%39K
-25.87%106K
184.48%49K
Net income
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
Net income continuous Operations
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
Minority interest income
Net income attributable to the parent company
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
8.71%-87.68M
-27.44%-27.89M
3.11%-18.04M
5.69%-18.79M
35.55%-22.96M
25.16%-96.05M
41.97%-21.89M
Basic earnings per share
70.40%-3.07
106.98%0.75
58.49%-5.5
39.56%-34
27.17%-9.2853
5.73%-10.37
8.51%-10.75
36.90%-13.25
30.12%-56.25
42.70%-12.75
Diluted earnings per share
70.40%-3.07
106.98%0.75
58.49%-5.5
39.56%-34
27.17%-9.2853
5.73%-10.37
8.51%-10.75
36.90%-13.25
30.12%-56.25
42.70%-12.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue -60.82%1.27M-84.59%1.06M-63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M
Operating revenue -60.82%1.27M-84.59%1.06M-63.79%986K11.66%15.53M-24.20%2.68M-21.12%3.24M86.46%6.89M5.91%2.72M219.04%13.91M863.76%3.54M
Cost of revenue
Gross profit
Operating expense -4.08%21.4M5.56%27.48M-13.55%23.03M-7.02%103.66M9.38%28.68M-3.23%22.31M8.06%26.03M-30.13%26.64M-15.97%111.49M-31.57%26.22M
Selling and administrative expenses -28.20%4.63M-31.04%6.38M-21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M
-General and administrative expense -28.20%4.63M-31.04%6.38M-21.63%6.67M15.93%30.62M-9.80%6.42M22.42%6.44M22.04%9.25M31.84%8.51M-7.42%26.41M-26.74%7.12M
Research and development costs 5.72%16.77M25.73%21.1M-9.75%16.37M-14.15%73.04M16.53%22.26M-10.81%15.87M1.64%16.78M-42.75%18.14M-18.32%85.08M-33.21%19.1M
Operating profit -5.56%-20.13M-38.00%-26.41M7.83%-22.05M9.69%-88.13M-14.62%-26M-0.65%-19.07M6.14%-19.14M32.73%-23.92M23.96%-97.58M40.23%-22.68M
Net non-operating interest income expense -54.53%457K-66.60%319K-22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K
Non-operating interest income -54.53%457K-66.60%319K-22.46%580K-24.21%1.24M-267.24%-1.47M115.67%1.01M350.47%955K769.77%748K1,142.42%1.64M1,447.69%876K
Other net income (expense) 837.04%506K20,521.71%31.35M-5,364.96%-13.37M129.67%54K-50.00%152K379.12%254K
Other non- operating income (expenses) 837.04%506K20,521.71%31.35M-5,364.96%-13.37M--------129.67%54K-50.00%152K379.12%254K--------
Income before tax -6.42%-19.17M129.11%5.25M-52.03%-34.84M9.44%-86.88M-27.87%-27.92M3.49%-18.01M9.27%-18.03M35.56%-22.92M25.16%-95.94M42.19%-21.84M
Income tax 213.79%91K-75.03%189K-38.46%24K650.00%795K-161.22%-30K167.44%29K1,510.64%757K-26.42%39K-25.87%106K184.48%49K
Net income -6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M
Net income continuous Operations -6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M
Minority interest income
Net income attributable to the parent company -6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -6.75%-19.26M126.93%5.06M-51.88%-34.86M8.71%-87.68M-27.44%-27.89M3.11%-18.04M5.69%-18.79M35.55%-22.96M25.16%-96.05M41.97%-21.89M
Basic earnings per share 70.40%-3.07106.98%0.7558.49%-5.539.56%-3427.17%-9.28535.73%-10.378.51%-10.7536.90%-13.2530.12%-56.2542.70%-12.75
Diluted earnings per share 70.40%-3.07106.98%0.7558.49%-5.539.56%-3427.17%-9.28535.73%-10.378.51%-10.7536.90%-13.2530.12%-56.2542.70%-12.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Meta Platforms
META
+3.51%
Coinbase
COIN
+2.30%
Amazon
AMZN
+1.30%
Apple
AAPL
+1.28%
Oracle
ORCL
+0.82%

Unlock the Full List